Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results

    Financial Results - Page 12

    Morepen Labs reports 107 percent increase in Q3, net profit at Rs 9.67 crores

    Morepen Labs reports 107 percent increase in Q3, net profit at Rs 9.67 crores

    Ruby Khatun Khatun23 Jan 2018 10:30 AM IST
    New Delhi: Morepen Laboratories Ltd has reported yet another growth-filled quarter by registering 107 percent rise in its net profit in Q3 of FY...
    Jubilant Life Sciences Q3 net up 80 percent to Rs 212.84 crore

    Jubilant Life Sciences Q3 net up 80 percent to Rs 212.84 crore

    Ruby Khatun Khatun18 Jan 2018 10:45 AM IST
    New Delhi: Drug firm Jubilant Life Sciences reported an 80.20 percent rise in its consolidated net profit to Rs 212.84 crore for the third quarter...
    Siemens Q4 net profit plunges 75 percent to Rs 624 crore

    Siemens Q4 net profit plunges 75 percent to Rs 624 crore

    Ruby Khatun Khatun26 Nov 2017 10:04 AM IST
    New Delhi: Siemens reported a sharp 74.94 percent decline in standalone net profit at Rs 623.77 crore for the fourth quarter to September on account...
    Sun Pharma Q2 net profit dives 59 percent at Rs 912.12 crore

    Sun Pharma Q2 net profit dives 59 percent at Rs 912.12 crore

    Ruby Khatun Khatun16 Nov 2017 10:15 AM IST
    New Delhi: Pharma major Sun Pharmaceutical Industries reported a 59.19 percent dip in consolidated net profit to Rs 912.12 crore for the quarter ended...
    Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore

    Cadila Healthcare Q2 net profit up 32 percent at Rs 503 crore

    Ruby Khatun Khatun15 Nov 2017 10:00 AM IST
    New Delhi: Drug firm Cadila Healthcare reported a 32.48 percent rise in its consolidated net profit to Rs 503.3 crore for the second quarter ended...
    Apollo Hospitals Q2 net dips 23 percent to Rs 71 crore

    Apollo Hospitals Q2 net dips 23 percent to Rs 71 crore

    Ruby Khatun Khatun15 Nov 2017 9:26 AM IST
    New Delhi: Apollo Hospitals Enterprise reported 22.92 percent dip in standalone net profit to Rs 70.90 crore for the September quarter of the current...
    Abbott India Q2 profit rises 83 percent to Rs 137.52 crore

    Abbott India Q2 profit rises 83 percent to Rs 137.52 crore

    Ruby Khatun Khatun14 Nov 2017 10:23 AM IST
    New Delhi: Drug firm Abbott India reported 83.31% jump in net profit to Rs137.52 crore for the September quarter on account of robust sales.It had...
    Morepen Labs reports 24 percent jump in its Q2 net profit

    Morepen Labs reports 24 percent jump in its Q2 net profit

    Ruby Khatun Khatun14 Nov 2017 10:16 AM IST
    New Delhi: Morepen Laboratories Ltd. has reported a stable set of numbers in the second quarter (Q2) of fiscal 2017-18. The company has registered a...
    Pfizer Q2 net dips 12 percent at Rs 111.15 crore

    Pfizer Q2 net dips 12 percent at Rs 111.15 crore

    Ruby Khatun Khatun14 Nov 2017 10:00 AM IST
    New Delhi: Drug firm Pfizer reported a 12 percent dip in standalone net profit to Rs 111.15 crore for the quarter ended September 30, 2017.The company...
    Suven Life Sciences Q2 net up 20 percent to Rs 32 crore

    Suven Life Sciences Q2 net up 20 percent to Rs 32 crore

    Ruby Khatun Khatun14 Nov 2017 9:23 AM IST
    New Delhi: Suven Life Sciences reported a 19.5 percent increase in net profit to Rs 31.74 crore for the second quarter ended September 30.The company...
    Sequent Scientific posts Rs 30.53 crore profit for Q2

    Sequent Scientific posts Rs 30.53 crore profit for Q2

    Ruby Khatun Khatun13 Nov 2017 9:45 AM IST
    New Delhi: Drug firm Sequent Scientific reported a consolidated net profit of Rs 30.53 crore for the quarter ending September 30.The company had...
    Hester Biosciences Q2 Net up 48 percent at Rs 8.85 crore

    Hester Biosciences Q2 Net up 48 percent at Rs 8.85 crore

    Ruby Khatun Khatun13 Nov 2017 9:10 AM IST
    New Delhi: Animal healthcare firm Hester Biosciences reported a 47.99 percent rise in its standalone net profit to Rs 8.85 crore for the September...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok